Tumor Biology

, Volume 35, Issue 10, pp 9949–9955 | Cite as

Adhesion to type V collagen enhances staurosporine-induced apoptosis of adrenocortical cancer cells

  • Tiziana Nardo
  • Geraldina Micalizzi
  • Roberto Vicinanza
  • Francesca De Iuliis
  • Ludovica Taglieri
  • Susanna ScarpaEmail author
Research Article


Adrenocortical carcinoma (ACC) is a rare and aggressive tumor characterized by poor prognosis and resistance to conventional chemotherapy. Many chemotherapy agents act determining apoptosis, therefore, studying the responsiveness of ACC to apoptosis inducing molecules, can help to identify possible conditions to promote cancer cell death. Tumor progression is strictly related to the interaction between cancer cells and stroma; yet, extracellular matrix remodeling regulates tumor cell proliferation and apoptosis. At this purpose, we have studied staurosporine-induced apoptosis of ACC cell line H295R adherent to different extracellular matrix molecules. H295R cells grown on plastic showed a low responsiveness to staurosporine, with an apoptotic rate of 24 %, as compared to breast cancer MCF7 cells, with an apoptotic rate of 60 %. The adhesion of H295R cells to type V collagen induced a significant increase of apoptosis up to 52 %; this effect was inhibited by anti-integrin alpha2 antibody. At the same time, the adhesion of H295R cells on polylysine, matrigel, lamimin, fibronectin, and type I-III collagens didn’t modify staurosporine-induced apoptosis. Staurosporine-treated H295R cells showed an increase of PARP cleavage and of annexin-V expression, when adherent to type V collagen. Yet, staurosporine induced Akt and Erk activation on H295R cells: the adhesion on type V collagen didn’t modify Akt activation, while determined a dramatic inhibition of Erk activation. The described data demonstrate that the adhesion to type V collagen specifically increases the responsiveness of ACC cells to staurosporine-induced apoptosis and that this is probably obtained through the inhibition of Erk activation.


Adrenocortical cancer Type V collagen Apoptosis Staurosporine 


  1. 1.
    Allolio M, Fassnacht M. Clinical review: Adrenocortical carcinoma clinical update. J Clin Endocrinol Metab. 2006;91(6):2027–37.CrossRefPubMedGoogle Scholar
  2. 2.
    Kirschner LS. The next generation of therapies for adrenocortical cancers. Trends Endocrinol Metab. 2012;23(7):343–50.CrossRefPubMedGoogle Scholar
  3. 3.
    Jubb AM, Harris AL. Biomarkers to predict the clinical efficacy of bevacizumab in cancer. Lancet Oncol. 2010;11(12):1172–83.CrossRefPubMedGoogle Scholar
  4. 4.
    Wu JM, Staton CA. Anti angiogenic drug discovery lessons from the past and thoughts for the future. Expert Opin Drug Discov. 2012;7(8):723–43.CrossRefPubMedGoogle Scholar
  5. 5.
    Lawnicka H, Kowalewicz-Kulbat M, Sicinska P, Altmann KH, Hofmann T, Stepien H. Resorcylic acid lactone L-783, 277 inhibits the growth of the human adrenal cancer cell line H295R in vitro. Int J Immunopathol Pharmacol. 2009;22(4):889–95.PubMedGoogle Scholar
  6. 6.
    Lawnicka H, Kowalewicz-Kulbat M, Sicinska P, Kazimierczuk Z, Grieb P, Stepien H. Anti-neoplastic effect of protein kinase CK2 inhibitor, DMAT, on growth and hormonal activity of human adrenocortical carcinoma cell line (H295R) in vitro. Cell Tissue Res. 2010;340(2):371–9.CrossRefPubMedGoogle Scholar
  7. 7.
    Roovers K, Assoian RK. Integrating the MAP kinase signal into the G1 phase of cell cycle machinery. Bioessays. 2000;22(9):818–26.CrossRefPubMedGoogle Scholar
  8. 8.
    Aguirre G. Genes and diseases in man and models. Prog Brain Res. 2001;131(1):663–78.CrossRefPubMedGoogle Scholar
  9. 9.
    Lee BH, Ruoslahti E. Alpha5beta1 integrin stimulates Bcl2 expression and cell survival through Akt, focal adhesion kinase and Ca2+/calmodulin dependent protein kinase IV. J Cell Biochem. 2005;95(6):1214–23.CrossRefPubMedGoogle Scholar
  10. 10.
    Frisch SM, Screaton RA. Anoikis mechanism. Curr Opin Cell Biol. 2001;13(5):555–62.CrossRefPubMedGoogle Scholar
  11. 11.
    Stupack DG, Puente XS, Boutsaboualoy S, Storgard CM, Cheresh DA. Apoptosis of adherent cells by recruitement of caspase-8 unligated integrins. J Cell Biol. 2001;155(3):459–70.PubMedCentralCrossRefPubMedGoogle Scholar
  12. 12.
    Denys H, Braems G, Lambein K, Pauwels P, Hendrix A, De Boeck A, et al. The extracellular matrix regulates cancer progression and therapy response: implications for prognosis and treatment. Curr Pharm Des. 2009;15(12):1373–84.CrossRefPubMedGoogle Scholar
  13. 13.
    Tang D, Lahti JM, Kidd VJ. Caspase-8 activation and bid cleavage contribute to MCF7 cellular execution in a caspase-3-dependent manner during staurosporine-mediated apoptosis. J Biol Chem. 2000;275(13):9303–7.CrossRefPubMedGoogle Scholar
  14. 14.
    Rainey WE, Bird IM, Sawetawan C, Hanley NA, McCarthy JL, McGee EA, et al. Regulation of human adrenal carcinoma cell (NCIH295) production of C19 steroids. J Clin Endocrinol Metab. 1993;77(3):731–7.PubMedGoogle Scholar
  15. 15.
    Vichaj V, Kirtikara K. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc. 2006;1(3):1112–6.CrossRefGoogle Scholar
  16. 16.
    Antonsson A, Persson JL. Induction of apoptosis by staurosporine involves the inhibition of expression of major cell cycle proteins at the G2/M checkpoint accompanied by alterations in Erk and Akt kinase activities. Anticancer Res. 2009;29(8):2893–8.PubMedGoogle Scholar
  17. 17.
    Luparello C, Sirchia R, Longo A. Type V collagen and protein kinase Cη down-regulation in 8701-BC breast cancer cells. Mol Carcinog. 2013;52(5):348–58.CrossRefPubMedGoogle Scholar
  18. 18.
    Souza P, Rizzardi F, Noleto G, Atanazio M, Bianchi O, Parra ER, et al. Refractory remodeling of the microenvironment by abnormal type V collagen, apoptosis, and immune response in non-small cell lung cancer. Hum Pathol. 2010;41(2):239–48.CrossRefPubMedGoogle Scholar
  19. 19.
    Sage H. Collagens of basement membranes. J Invest Dermatol. 1982; 79 (1): 51 s-59sGoogle Scholar
  20. 20.
    Ruggiero F, Champliaud MF, Garrone R, Aumailley M. Interactions between cells and collagen V molecules or single chains involve distinct mechanisms. Exp Cell Res. 1994;210(2):215–23.CrossRefPubMedGoogle Scholar
  21. 21.
    Luparello C, David F, Campisi G, Sirchia R. T47-D cells and type V collagen: a model for the study of apoptotic gene expression by breast cancer cells. Biol Chem. 2003;384(6):965–75.CrossRefPubMedGoogle Scholar
  22. 22.
    Luparello C, Sirchia R. Type V collagen regulates the expression of apoptotic and stress response genes by breast cancer cells. J Cell Physiol. 2005;202(2):411–21.CrossRefPubMedGoogle Scholar
  23. 23.
    Sirchia R, Ciacciofera V, Luparello C. Tumor cell collagen interactions: Identification and semi-quantitative evaluation of selectively expressed genes by combination of differential display and multiplex PCR. Biol Proced Online. 2003;5(4):222–7.PubMedCentralCrossRefPubMedGoogle Scholar
  24. 24.
    Vasaturo F, Malacrino C, Sallusti E, Coppotelli G, Birarelli P, Giuffrida A, et al. Role of extracellular matrix in regulation of staurosporine-induced apoptosis in breast cancer cells. Oncol Rep. 2005;13(4):745–50.PubMedGoogle Scholar
  25. 25.
    Marastoni S, Ligresti G, Lorenzon E, Colombatti A, Mongiat M. Extracellular matrix: a matter of life and death. Connect Tissue Res. 2008;49(3):203–6.CrossRefPubMedGoogle Scholar
  26. 26.
    Hu M, Polyak K. Microenvironmental regulation of cancer development. Curr Opin Genet Dev. 2008;18(1):27–34.PubMedCentralCrossRefPubMedGoogle Scholar
  27. 27.
    Testa JR, Bellacosa A. AKT plays a central role in tumorigenesis. Proc Natl Acad Sci U S A. 2001;98(20):10983–5.PubMedCentralCrossRefPubMedGoogle Scholar
  28. 28.
    Park EM, Cho S. Enhanced ERK dependent CREB activation reduces apoptosis in staurosporine treated neuroblastoma SK-N-BE2C cells. Neurosci Lett. 2006;402(13):190–4.CrossRefPubMedGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2014

Authors and Affiliations

  • Tiziana Nardo
    • 1
  • Geraldina Micalizzi
    • 1
  • Roberto Vicinanza
    • 1
  • Francesca De Iuliis
    • 1
  • Ludovica Taglieri
    • 1
  • Susanna Scarpa
    • 1
    Email author
  1. 1.Experimental Medicine DepartmentSapienza University of RomeRomeItaly

Personalised recommendations